George Golumbeski, Director at ENANTA PHARMACEUTICALS INC (ENTA), sold 27,000 shares at $90.03 ($2.4M) on 2019-02-11, disclosed to the SEC on 2019-02-13.
Open-market sale of $2.4M ENTA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.03 | 2,272 | $205K | 8.4% |
| 2 | $90.03 | 2,272 | $205K | 8.4% |
| 3 | $90.07 | 11,228 | $1.0M | 41.6% |
| 4 | $90.07 | 11,228 | $1.0M | 41.6% |
| Total | $90.06 avg | 27,000 | $2.4M | 100% |
| Filing → |
| STTK | BUY | 2022-04-26 | $193K | — | Filing → |
| ENTA | SELL | 2019-03-06 | $962K | — | Filing → |